Please assess the completion status of the following clinical trial:

Trial Title: Supportive Treatment of Severe Heart Failure by Renal Denervation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* NYHA III-IV~* ejection fraction \<45 %~* 6-minute walking test under 440m~Exclusion Criteria:~* Unstable hemodynamic state~* uncooperation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Renal nervous denervation. (Type: ACTIVE_COMPARATOR): Renal nervous denervation is performed to the patients who do not response properly to conventional therapy. The patients are randomised according to the waiting list principle.
- Renal nervous denervation (delayed) (Type: ACTIVE_COMPARATOR): Renal nervous denervation is performed after six months on the waiting list

Based on this trial design, predict the completion outcome and termination type (if applicable).